Emily Paxhia joins us and parallels her sailing experience and its applications to the Cannabis law environment: “Just like in sailing, overcorrecting, is also, bad. It’s not about overcorrecting and overreacting, it’s about fine calibrations of what you’re doing and it’s about using the information you have to do that.”


Seth Adler: Emily Paxhia, returns. Welcome, to Cannabis Economy. I'm your host, Seth Adler. Download episodes on [canneconomy 00:00:05] dot com. That's two nn's in the word economy, a ton of direct insight up on canneconomy dot com, these days. Including, from Emily Paxhia.
This is going to be available, also, as a video and, so, check that out on canneconomy dot com, if you'd like. First, a word from Bedrocan and, then, Emily Paxhia.
"Bedrocan is a patient driven, global pharmaceutical minded cannabis company. Their entire end-to-end process is GMP certified through Dutch and, ultimately, European authorities. Bedrocan is the market leader in Europe for medical cannabis and has been the sole supplier to the Dutch government for 16 years. Through the Dutch government, Bedrocan provides product to 15 countries, currently.
"As a science based company, Bedrocan invests in clinical research. The Leiden University conducted a double blind, placebo controlled, clinical trial on fibromyalgia with Bedrocan products which yielded promising results. They're, now, working on a follow-up to that study. Bedrocan is also working on the extent to which cannabis can reduce a reliability on opioids.
"Bedrocan believes that clinical research is key for the future of the company, standardized product, the industry and the patient. Visit Bedrocan dot com, for more information."
All right. We're navigating the tides, once again, with The Paxhia, represented by Emily Paxhia, today. It's a sailing anecdote, is what we're doing.

Emily Paxhia: Absolutely. The name of our company is Poseidon, which has very much to do with the god of the sea and the reason for that is that, Morgan, my brother, and I grew up sailing together, with our family and, as we were embarking into this industry, we likened the conditions of investing into a very unknown and new industry, as something like navigating the unknown and unpredictable conditions of sailing in the sea.
When, Seth... when you asked me to come up with a sailing anecdote, this one moment came very much into mind and I was saying that, the thing about sailing is, that's so much like cannabis is, that the moment when things start to go wrong, it becomes... things start to move very quickly, they start to accelerate in the direction of the thing that's going wrong. If you don't get very clear and pay very close attention to the conditions and to what's happening in those circumstances, you can find yourself, at best case scenario, very uncomfortable and, at worst case scenario, in quite a bit of pain or worse, in real trouble. Peril at the sea.
My anecdote has to do with how you monitor and adjust to a situation very quickly. Morgan and I always talk about being nimble in this industry and not being locked into a rigid line of thinking, which, some people, when they come to us, they're looking for us to have had decades of investment experience in other categories and we, just, don't. Because, frankly, we're pretty young and it takes a little bit of being fearless to jump into this industry and, so, I think being a little bit younger gives you, just, that level of fearlessness, because you, just, don't know any better. Who was it that said, "I'm glad I didn't know any better, because I wouldn't have done anything"? Something to that effect.

Read the full transcript:

Become a member to access to webinars, quarterly reports, contributor columns, shows, excerpts, and complete podcast transcripts

Become a Member

Already a member? Login here.